Turning off a gastric stimulator and its effect on insulin in gastroparesis
Tests how pausing a stomach stimulator changes insulin and sugar levels in gastroparesis.
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Registry title
- Effect of Gastric Electrical Stimulation on Serum Insulin Levels
- Status
- Recruiting
- People taking part
- 32 people, planned
- Started
- 23 Jul 2026
- Expected to end
- 31 Jul 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Gastric Electrical Stimulator
- Record updated
- 1 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with gastroparesis (slow stomach emptying) who already have a gastric electrical stimulator (GES) implanted. It studies how turning the device off for up to four hours changes insulin, C-peptide, GLP-1 and glucose levels.
- Age
- 18 years and older.
- Sex
- All sexes can join.
- Disease stage
- A documented diagnosis of gastroparesis. The condition list says nondiabetic gastroparesis.
- Earlier treatment
- A GES device must have been implanted for at least 3 months. People taking prescribed insulin for diabetes cannot join.
Main reasons for not taking part
- Pregnancy
- Past allergic reaction to the sticky pads used for EKG (heart tracing) leads
- Not able to give informed consent
- Not willing to give up to 8 blood samples of 5 ml
- Not willing to lie in a bed for up to 5.5 hours
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- At least 18 years of age
- Documented diagnosis of gastroparesis
- Not taking diabetic prescribed exogenous insulin
- Patient has a GES device that has been implanted for at least 3 months
- Willing to give up to 8 blood samples
- Willing to lie in a bed for up to 5.5 hours
Who cannot take part
- History of allergic reaction to EKG lead placement adhesives
- Pregnancy
- Unable to give informed consent
- Unwilling to give up to 8 5 ml blood samples
- Unwilling to lie in a bed for up to 5.5 hours
Where in United States
- Indiana University HospitalIndianapolis, United StatesContact: Maureen V Schilling, BSTaking people
About the trial
What the trial wants to find out
The goal of this study is to determine how much effect turning off an individual's Gastric Electrical Stimulator (GES) for up to four hours will have on levels of insulin, C-peptide, GLP-1 and glucose levels.
The 2 groups in the trial
- The OFF GroupTreatment being tested
This group of subjects will have their GES interrogated and observed as well as having the device turned off for the duration of the experiment. The device will then be re-interrogated and turned back on at the end of the experiment.
Treatment: Gastric Electrical Stimulator
- Control GroupNo study treatment, for comparison
This group of subjects will undergo the same procedures as the experimental group, except that their GES will not be turned off during the experimental period.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Defining the Effect of Gastric Electrical Stimulation on Serum Insulin Levels in Human Subjects
- Plain-language title
- Turning off a gastric stimulator and its effect on insulin in gastroparesisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 1 October 2026